BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16507269)

  • 1. Hodgkin disease/lymphoma. Clinical practice guidelines in oncology.
    Hoppe RT; Advani RH; Bierman PJ; Bloomfield CD; Buadi F; Djulgegovic B; Forero A; Gordon LI; Hernandez-Ilizaliturri FJ; Kaminski MS; Love G; Maloney DG; Mauch PM; Moore JO; Schilder RJ; Weiss L; Winter JN; Yahalom J; Zelenetz AD;
    J Natl Compr Canc Netw; 2006 Mar; 4(3):210-30. PubMed ID: 16507269
    [No Abstract]   [Full Text] [Related]  

  • 2. Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
    Hoppe RT; Advani RH; Ai WZ; Ambinder RF; Aoun P; Bello CM; Benitez CM; Bernat K; Bierman PJ; Blum KA; Chen R; Dabaja B; Forero A; Gordon LI; Hernandez-Ilizaliturri FJ; Hochberg EP; Huang J; Johnston PB; Kaminski MS; Kenkre VP; Khan N; Maloney DG; Mauch PM; Metzger M; Moore JO; Morgan D; Moskowitz CH; Mulroney C; Poppe M; Rabinovitch R; Seropian S; Smith M; Winter JN; Yahalom J; Burns J; Ogba N; Sundar H
    J Natl Compr Canc Netw; 2017 May; 15(5):608-638. PubMed ID: 28476741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for the investigation and management of nodular lymphocyte predominant Hodgkin lymphoma.
    McKay P; Fielding P; Gallop-Evans E; Hall GW; Lambert J; Leach M; Marafioti T; McNamara C;
    Br J Haematol; 2016 Jan; 172(1):32-43. PubMed ID: 26538004
    [No Abstract]   [Full Text] [Related]  

  • 4. Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Eichenauer DA; Engert A; Dreyling M;
    Ann Oncol; 2011 Sep; 22 Suppl 6():vi55-8. PubMed ID: 21908505
    [No Abstract]   [Full Text] [Related]  

  • 5. NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.
    Hoppe RT; Advani RH; Ai WZ; Ambinder RF; Aoun P; Armand P; Bello CM; Benitez CM; Bierman PJ; Chen R; Dabaja B; Dean R; Forero A; Gordon LI; Hernandez-Ilizaliturri FJ; Hochberg EP; Huang J; Johnston PB; Kaminski MS; Kenkre VP; Khan N; Maddocks K; Maloney DG; Metzger M; Moore JO; Morgan D; Moskowitz CH; Mulroney C; Rabinovitch R; Seropian S; Tao R; Winter JN; Yahalom J; Burns JL; Ogba N
    J Natl Compr Canc Netw; 2018 Mar; 16(3):245-254. PubMed ID: 29523663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Newly Diagnosed Classical Hodgkin Lymphoma.
    Straus DJ
    Clin Lymphoma Myeloma Leuk; 2020 Sep; 20 Suppl 1():S87-S88. PubMed ID: 32862883
    [No Abstract]   [Full Text] [Related]  

  • 7. SEOM clinical guidelines for the treatment of Hodgkin's lymphoma.
    Rueda Domínguez A; Alfaro Lizaso J; de la Cruz Merino L; Gumá I Padró J; Quero Blanco C; Gómez Codina J; Llanos Muñoz M; Martinez Banaclocha N; Rodriguez Abreu D; Provencio Pulla M
    Clin Transl Oncol; 2015 Dec; 17(12):1005-13. PubMed ID: 26497354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VII. Management of nodular lymphocyte-predominant Hodgkin lymphoma.
    Eichenauer DA; Engert A
    Hematol Oncol; 2013 Jun; 31 Suppl 1():47-50. PubMed ID: 23775649
    [No Abstract]   [Full Text] [Related]  

  • 9. Nodular lymphocyte predominant hodgkin lymphoma: biology, diagnosis and treatment.
    Goel A; Fan W; Patel AA; Devabhaktuni M; Grossbard ML
    Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):261-70. PubMed ID: 24650975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hodgkin lymphoma (Hodgkin disease)].
    Naumann UK; Käser L; Vetter W
    Praxis (Bern 1994); 2006 Nov; 95(44):1697-703; quiz 1704, 1706. PubMed ID: 17111877
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hodgkin's disease or lymphoma].
    Legal L
    Rev Infirm; 2006; (122):20-1. PubMed ID: 16881451
    [No Abstract]   [Full Text] [Related]  

  • 12. [Standard therapy and research questions in Hodgkin lymphoma].
    Suzuki T
    Rinsho Ketsueki; 2012 Oct; 53(10):1615-23. PubMed ID: 23037734
    [No Abstract]   [Full Text] [Related]  

  • 13. Hodgkins disease.
    Ferme C; Cosset JM; Fervers B; Sebban C; Cutuli B; Henry-Amar M; Stines J; Giammarile F; Bey P; Carella AM; Philip T;
    Br J Cancer; 2001 May; 84 Suppl 2(Suppl 2):55-60. PubMed ID: 11355971
    [No Abstract]   [Full Text] [Related]  

  • 14. Childhood Hodgkin and non-Hodgkin lymphomas.
    Leventhal BG; Kato GJ
    Pediatr Rev; 1990 Dec; 12(6):171-9. PubMed ID: 2287598
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphoma and pregnancy.
    Ward FT; Weiss RB
    Semin Oncol; 1989 Oct; 16(5):397-409. PubMed ID: 2678489
    [No Abstract]   [Full Text] [Related]  

  • 16. NCCN practice guidelines for Hodgkin's disease. National Comprehensive Cancer Network.
    Oncology (Williston Park); 1999 May; 13(5A):78-110. PubMed ID: 10370924
    [No Abstract]   [Full Text] [Related]  

  • 17. Early stage, bulky Hodgkin lymphoma patients have a favorable outcome when treated with or without consolidative radiotherapy: potential role of PET scan in treatment planning.
    Nguyen VT; Pophali PA; Tsai JP; Jagadeesh D; Dean RM; Pohlman B; Morgan DS; Greer JP; Smith MR; Hill BT; Reddy NM
    Br J Haematol; 2017 Nov; 179(4):674-676. PubMed ID: 27409578
    [No Abstract]   [Full Text] [Related]  

  • 18. [[Therapeutic and prognostic significance of staging in malignant lymphoma].
    Hansz J
    Z Gesamte Inn Med; 1981 Nov; 36(22):870-3. PubMed ID: 7043920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodular lymphocyte predominant Hodgkin lymphoma with non-invasive or early invasive growth pattern suggests an early step of the disease with a highly favorable outcome.
    Carbone A; Spina M; Gloghini A; Ponzoni M; Doglioni C; Tirelli U
    Am J Hematol; 2013 Feb; 88(2):161-2. PubMed ID: 23349009
    [No Abstract]   [Full Text] [Related]  

  • 20. Childhood cancer: common cancers.
    Campbell R
    Nurs Mirror; 1980 Aug; 151(9):viii-xii. PubMed ID: 6902351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.